News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Alliances (World)
MorphoSys AG Tanks 20% on Celgene (CELG) Cancer Pact Breakup News 3/27/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licence Of Anamorelin In China, Hong Kong And Macao 3/26/2015
Probi Signs Agreement With Leading VMS Supplier In Canada 3/26/2015
Asahi Kasei Pharma (AHKSY.PK) Selects Evotec AG (EVTG.F) As Its Partner For Ion Channel Drug Discovery 3/26/2015
Evolva A/S And Valent BioSciences Corporation To Co-Develop Agricultural Bioactives 3/26/2015
Green Cross And Nanolek Announce Strategic Partnership For Biologics Commercialisation In Russia 3/26/2015
Recipharm AB And Adroit Science Form Collaboration To Expand Service Offering 3/26/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/26/2015
Phosphagenics Limited (POH.AX) Signs License Agreement To Expand TPM-Based Animal Nutrition Products To The UK And Ireland 3/25/2015
The Institut Pasteur Announces An Alliance With Integragen To Strengthen Its High-Throughput Sequencing Activities In Microbiology 3/25/2015
Denator AB Enters Into Collaboration With Newly Established State-Of-The-Art European Institute For Clinical Applications 3/24/2015
Mercachem Choose Cresset’s Torch And Spark Molecule Design Software To Support Their Growing Medicinal Chemistry Service Business 3/24/2015
Qu Biologics Begins Research Collaboration With University of Rochester, New York 3/24/2015
Probi AB And Wageningen University Enter Long-Term Research Collaboration 3/24/2015
Portage Biotech's Biohaven Enters Into Exclusive Formulation Agreement And Global License With Catalent Pharma Solutions (CTLT) For Lead Product 3/24/2015
Affimed Therapeutics AG (AFMD) Completes Tandab Development Candidate Activities Meeting Amphivena's And Janssen Biotech Inc. (JNJ)'s Criteria And Achieves Milestone Ahead Of Schedule 3/24/2015
Stemedica Cell Technologies, Inc. Obtains An Exclusive Worldwide License For Stem Cell Stabilization And Preservation Technologies 3/24/2015
Another Day, Another $456 Million Cancer Pact for Eli Lilly (LLY) 3/23/2015
Can-Fite BioPharma (CFBI) Signs Multi-Million Dollar Distribution Agreement For CF101 In Canada With Cipher Pharmaceuticals (DND.TO) 3/23/2015
Yew Bio-Pharm Group Signs Sales Agreement And Receives Subsidy Grant From The Finance Department Of Heilongjiang Province, China 3/23/2015
Zai Lab In-licenses Potential Liver Cancer Drug From Bristol-Myers Squibb (BMY) 3/23/2015
Horizon Discovery Group plc And ArcherDX Sign OEM Agreement 3/23/2015
ISA Scientific, Yissum Ltd., Hadasit Ltd., And The Kennedy Trust For Rheumatology Research To Collaborate On Treating Diabetes And Other Serious Health Conditions With Cannabidiol 3/23/2015
Evotec AG (EVTG.F) Inherits Sanofi (SAN.PA)'s Troubled Division in €250 Million Long Term Drug Discovery Deal 3/20/2015
ImmunoCellular Therapeutics, Ltd (IMUC) Chooses PharmaCell As Contract Manufacturing Partner For Its Phase III Program In Europe 3/20/2015
The Cooperative Research Centre for Cell Therapy Manufacturing Release: International Regenerative Medicine Groups Form Strategic Alliance To Commercialize Cell Therapies 3/20/2015
AstraZeneca PLC (AZN), Daiichi Sankyo (DSNKY) in $825 Million Drug Tie-Up 3/19/2015
GAP And IMI To Sign MOU To Accelerate Alzheimer's Drug Development 3/19/2015
Big Names Such as GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), and Pfizer (PFE) Invest in $100 Million Alzheimer's Venture Fund 3/18/2015
Gentronix Limited Announces Multi-Year Agreement For Provision Of GreenScreen HC Technology To Major Chinese Research Institute, Shanghai Institute Of Materia Medica 3/18/2015
TaiGen Biotechnology Announces Burixafor Collaboration With Celldex (CLDX) And The University Hospital Carl Gustav Carus Dresden In Germany 3/18/2015
Lexicon Pharmaceuticals, Inc. (LXRX) And Ipsen (IPN.PA) Expand Their Licensing And Commercialization Agreement For Telotristat Etiprate To Include Canada 3/18/2015
St. George's University And Rutgers University Launch Joint Veterinary Partnership 3/18/2015
SYGNIS Signs Non-Exclusive Distribution Agreement With SOPACHEM For Trueprime Product Family In Belgium 3/18/2015
Galapagos (GLPG.BR) Ends Long-Running R&D Inflammation Pact With Janssen Pharmaceutica N.V. 3/17/2015
VALNEVA Announces Signing Of An Exclusive License Agreement On EB66 Cell Line For Human And Veterinary Vaccines In China 3/17/2015
Genedata AG Partners With Bayer Pharma AG On Innovative Workflow Platform For High-Throughput Cell Line Development 3/17/2015
BioInvent (BOVNF) Announces Plan To Initiate Clinical Development Of TB-403 In Pediatric Cancer Together With ThromboGenics Ltd. (THR.BR) 3/17/2015
Taconic Biosciences Strengthens Japanese Distribution And Breeding Partnerships 3/17/2015
Emergent BioSolutions (EBS) Signs Agreements With Oxford University, GlaxoSmithKline (GSK), And National Institute of Allergy And Infectious Diseases (NIAID) For The Production Of An MVA Ebola Zaire Vaccine Candidate 3/16/2015
ARTES Biotechnology And Boehringer Ingelheim Animal Health Announce Collaboration 3/16/2015
Second Genome And Evotec AG (EVTG.F) To Collaborate In Microbiome Discovery And Development 3/13/2015
Vigilant Biosciences Announces Agreement With Biotech-Igg AB For Exclusive Distribution Of The OncAlert Oral Cancer Risk Assessment System In Scandinavia 3/11/2015
Shanghai Pharmaceutical Co., Ltd. Forms Online Drug Distribution JV 3/11/2015
Toolgen And Thermo Fisher Scientific (TMO) Sign License Agreement For CRISPR/Cas9 Genome Editing Technology 3/10/2015
SYGNIS AG Signs Non-Exclusive Distribution Agreement For Trueprime Product Family With OZYME France 3/10/2015
14M Genomics And The European Organization For Research And Treatment Of Cancer Collaborate On Genomic Profiling For Clinical Trials 3/10/2015
NRGene And International Researchers Team To Map Key Wheat Genome 3/10/2015
Innate Pharma (IPH.PA ) Collaborates With NCIC Clinical Trials Group On The Phase I/II Trial Of IPH2201 In Ovarian Cancer 3/9/2015
Altasciences And ITR Laboratories Form A Strategic Alliance 3/9/2015
Pfenex (PFNX) Exercises Glide Contract Extension For Solid Dose Formulation Of Recombinant Protective Antigen (rPA)-Based Anthrax Vaccine 3/9/2015
ModiQuest Research And Cellectis (ALCLS) To Collaborate On Antibody Generation For Potential CAR Development 3/6/2015
Midatech Pharma Plc Release: Research Collaboration Signed With Global Pharmaceutical Company 3/6/2015
Altasciences And ITR Laboratories Form A Strategic Alliance 3/5/2015
Bristol-Myers Squibb (BMY) Bets $975 Million on Bavarian Nordic (BAVA.CO)'s Prostate Cancer Vaccine 3/5/2015
AstraZeneca PLC (AZN), University of Cambridge in Tie-Up to Identify, Train, and Mentor Biotech Startups 3/4/2015
SYGNIS AG Signs Initial Distribution Agreement For The Asian Market For The Trueprime Product Family With Japanese Funakoshi Co. 3/4/2015
Synpromics Announces New Collaboration In AAV Based Gene Therapy Vector Development 3/4/2015
Fidelta Achieves Milestone In Collaboration With LEO Pharma 3/3/2015
Genedata Biologics Licensed By Pfizer (PFE) 3/3/2015
New Projects For Image Interpretation And Management In Clinical Trials Totaling €1.53M For MEDIAN Technologies 3/3/2015
ISA Pharmaceuticals Signs R&D Agreement With Shin Nippon Biomedical Laboratories 3/3/2015
Athersys, Inc. (ATHX) And Chugai Pharmaceutical Co., Ltd. (Japan) Enter License Agreement And Collaboration To Develop Multistem Cell Therapy For Ischemic Stroke In Japan 3/2/2015
Genmab A/S (GEN.CO) Announces That Agreement To Transfer Ofatumumab Collaboration To Novartis AG (NVS) Is Now Effective 3/2/2015
SCIEX And Labor Berlin Collaboration To Advance Forensic Testing 3/2/2015
Clinigen Group Signs Distribution Agreement With MSD UK For Clinical Trial Supply Services 2/27/2015
Triphase Accelerator Enters Into Academic Center Collaboration With Sunnybrook Research Institute To Advance Development Of Bi-Specific Antibody In The Interest Of Cancer Patients 2/27/2015
Eddingpharm Gains China Rights To Amarin (AMRN)'s Omega-3 Product In $169 Million Deal 2/27/2015
Vernalis PLC (VNLPY.PK) Licenses Proprietary ARA Technology 2/26/2015
AstraZeneca PLC (AZN) Taps Startup for $122.5 Million Autoimmune Pact 2/26/2015
Acceliant Announces Its Partnership With Lupin Pharmaceuticals, Inc. 2/25/2015
The Medicines Patent Pool Signs Licensing Agreement With MSD For Paediatric Formulations Of Raltegravir 2/24/2015
Roche (RHHBY) And BioMed X Collaborate To Develop Nanomaterial-Based Biosensors For Near-Patient Testing 2/24/2015
University of Tubingen And Mediso Enter Into A Collaboration To Develop A Preclinical PET Insert For Simultaneous Acquisition In High Field MRI Systems 2/23/2015
Mylan Inc. (MYL) Signs Exclusive Agreement With Gilead (GILD) To Distribute Sovaldi And Harvoni In India 2/23/2015
Nakashima And Teijin Limited To Establish Joint Venture For Global Expansion Of Japanese-Made Medical Device Business 2/23/2015
The Gene Center At Ludwig-Maximilians-Universität München, Germany And ExpreS2ion Biotechnologies> Enter A Licensing Agreement For Use Of The ExpreS2 Technology Platform 2/23/2015
Georgia State University Out-Licenses Leukemia Drug To China's Cisen Pharma 2/23/2015
Crossbeta Biosciences B.V. To Supply PerkinElmer, Inc. (PKI) Stable Oligomers For Use As AlphaLISA Analytes 2/23/2015
Sterigenics International, Inc. And Nordion Announce Landmark Canada-U.S. Partnership Agreement To Provide A Long-Term, Reliable Supply Of Medical Isotopes 2/20/2015
Queen Mary University Of London And Takeda (TKPYY) Announce Research Collaboration To Develop Novel Therapies in Gastroenterology 2/20/2015
Sanofi (SAN.PA): Deals Like the One Made With Tiny Lead Pharma Will Not Replace In-House R&D 2/19/2015
Bionovion Enters Commercial Immune Oncology Collaboration With Genmab A/S (GEN.CO) 2/19/2015
ErgoMed Announces Co-Development Agreement With Dilaforette For Sickle-Cell Disease Treatment 2/19/2015
Eagle Pharmaceuticals (EGRX), Teva Pharmaceutical Industries (TEVA) Forge $120 Million Leukemia Drug Pact 2/18/2015
Amarantus BioSciences, Inc. Announces First Alzheimer's Biomarker Services Collaboration For Lympro Test With Anavex Life Sciences Corp. (AVXL) 2/18/2015
NYU Langone Medical Center, Technion-Israel Institute Of Technology To Forge Groundbreaking Partnership In Cancer Research 2/18/2015
Immuron Signs Agreement To Sell Travelan In China 2/17/2015
Lupin Ltd. (LUPN.BO) And Celon Announce Strategic Development And Licensing Agreement For Generic Advair Diskus 2/17/2015
WuXi PharmaTech Co., Ltd. Enters Into $165 Million Syndicated Loan Agreement 2/17/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Dako A/S (Acquired by Agilent Technologies, Inc.) (A) And Ono Pharmaceutical Company, Ltd. Announce Collaboration On Development Of PD-L1 Companion Diagnostic Test For Investigational Cancer Drug Opdivo(Nivolumab) 2/16/2015
Reproductive Health Science Ltd (ASX:RHS) Signs Two New Distributor Agreements 2/16/2015
TiGenix And Lonza Group Ltd. (LZAGY.PK) Sign Agreement For The Manufacture Of Stem Cell-Based Treatment Of Complex Perianal Fistulas In Crohn's Disease 2/12/2015
BIOCEO15: BioLineRx Ltd. CEO Touts New Celiac Drug, Fleshes Out Novartis AG (NVS) Partnership Terms 2/11/2015
Government Joins Forces With PUP And Xenophon To Stifle Biotech Innovation 2/11/2015
Boehringer Ingelheim Corporation Renews Global Technology Collaboration Agreement With VTU Technology 2/10/2015
SIB Swiss Institute Of Bioinformatics Designated An FAO Reference Centre 2/10/2015
Merck & Co. (MRK) Abandons Highly Visible JV Venture With Simcere Pharmaceutical Group 2/9/2015
CrystalGenomics Partners With Daewoong Pharmaceutical For Acelex Commercialization In Korea 2/9/2015
Helsinn Group Signs Exclusive Agreement With Mundipharma For Distribution And Licensing Of Netupitant/Palonosetron (NEPA) In Brazil 2/9/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Extends Distribution Agreement With Menarini Group For Emtrix To Russia 2/9/2015
Easton Pharmaceuticals (OP: EAPH) Provides Update On Its Medicated Markets Partnership, Joint Initiatives And The Booming Medical Marijuana Climate In California For January 2015 2/9/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 2/6/2015
Cerus Corporation (CERS) And SunCoast Blood Bank Enter Into Agreement For The Use Of INTERCEPT Platelets And Plasma 2/5/2015
TTP LabTech Ltd. And Almac Group’s Strategic Alliance Consolidates Fluorescence Lifetime Technology To Form A One-Stop Shop For Compound Screening 2/5/2015
Biolin Scientific And Nanion Technologies Have Entered Into A Licensing Agreement 2/5/2015
MedImmune (AZN) And The AstraZeneca PLC (AZN) Announce Partnership To Advance Protein Formulation Science 2/5/2015
Isofol Medical AB Appoints The Sage Group To Identify Strategic Partnerships For Its Novel Modufolin® Chemotherapy Asset 2/4/2015
Consort Medical Signs Multi–Year Supply Agreement For Its Proprietary Integrated Dose Counter (IDC) System 2/4/2015
Moderna Therapeutics, Inc. And Institut Pasteur Sign Strategic Research Collaboration 2/3/2015
TEMIS Signs Large License Deal In The Swiss Reinsurance Industry 2/3/2015
Collaboration Between AYOXXA And Singapore Eye Research Institute 2/3/2015
Helsinn Group Grants Stendhal International Exclusive Rights To The Distribution And Marketing Of Netupitant-Palonosetron (NEPA) In Multiple Countries Of Latin America 2/2/2015
Horizon Discovery Group Selected As Core Facility By Tri-Institutional Therapeutics Discovery Institute 2/2/2015
EMD Millipore Announces Agreement With Precision Biologics To Provide Upstream Process Development Services 2/2/2015
NIHR Announces Partnership With Janssen To Investigate Why Current Rheumatoid Arthritis Biological Treatments Fail In A Third Of Patients 2/2/2015
Genticel Licenses Vaxiclase Platform To Serum Institute of India, Ltd. For Use In Pertussis Vaccines 2/2/2015
Mylan (MYL), Theravance (THRX) Partner Up for $265 Million COPD Pact 2/2/2015
AstraZeneca PLC (AZN) Hooks Up With Four Top R&D Institutions for CRISPR R&D 1/30/2015
Roche (RHHBY) and Qualcomm Partner Up for Remote Patient Monitoring 1/30/2015
Fosun Pharma Seeking Hospital Partnership In Heilongjiang Province 1/29/2015
OSE Pharma Appoints Simbec-Orion To Conduct Its Tedopi® Phase 3 International Clinical Trial In Advanced Lung Cancer Patients 1/29/2015
Biogen Idec (BIIB), Fondazione Telethon And Ospedale San Raffaele Announce Global Collaboration To Develop Gene Therapies For Hemophilia 1/29/2015
Merck Selects Credit360 To Manage Sustainability Data Consistently Across Their Global Organization 1/29/2015
MicroConstants China In-Licenses Global Rights Of AA98 Antibody Drug Candidates From Institute Of Biophysics, Chinese Academy Of Sciences 1/29/2015
Symphogen Regains Rights To Sym004 1/29/2015
TxCell Receives EUR 1 Million Milestone Payment Regarding Ovasave® Collaboration Agreement From Trizell 1/29/2015
Merck KGaA (MKGAF.PK) Walks Away From $625 Million Deal With Symphogen A/S 1/29/2015
Cord Blood Registry And China Cord Blood Corporation Enter Into Strategic Collaboration 1/28/2015
Luxembourg Institute Of Health Research Dedicated To Life 1/28/2015
AstraZeneca PLC (AZN) Chooses Box To Power Enterprise Content Collaboration For All Employees 1/27/2015
Prima Biomed (PRR.AX) Release: Financial Milestone Payment To Be Received From GlaxoSmithKline (GSK) 1/27/2015
PreAnalytiX, NuGEN Technologies, Inc. And RUCDR Infinite Biologics Partner To Develop Clinically Validated RNA-Seq Workflow For Whole Blood Samples 1/27/2015
Yissum And Phytotech Medical To Collaborate On Novel Delivery System For Medical Cannabis 1/26/2015
Mylan Inc. (MYL) Expands Hepatitis C Licensing Agreement With Gilead Sciences, Inc. (GILD) To Include Investigational Pan-Genotypic Agent 1/26/2015
With Some Help, GlaxoSmithKline (GSK) Believes They Have Found Cancer's "Achilles Heel" 1/23/2015
Immune Therapeutics, Inc. Announces Agreement With KRS Global Biotechnology, Inc. 1/23/2015
Celgene (CELG) Bets Big on Canada's Zymeworks 1/22/2015
Curis, Inc. (CRIS), Aurigene Discovery Technologies Limited Forge $415 Million+ Immuno-Oncology Pact 1/22/2015
New Oncology And University Hospital Oslo Announce Genomic Profiling Collaboration 1/22/2015
Heptares Technology Enables Breakthrough In Drug Discovery Collaboration With AstraZeneca PLC (AZN) 1/22/2015
ImmuPharma plc (IMM.L) Release: Landmark Collaboration Agreement & Commencement Of Pivotal Phase 3 Lupuzor™ Study With Simbec-Orion Deal Provides Powerful Validation For Lupuzor™ 1/22/2015
Johnson & Johnson (JNJ), Takeda (TKPYY) Open Up Israeli Biotech Incubator to Develop New Cures for Old Ills 1/21/2015
Mitsubishi Gas Forms Asian Biologics CRO Partnership With Catalent 1/21/2015
SYGNIS Signs Distribution Agreement With bioNova cientifica, s.l. For Its Innovative TruePrime™Single Cell WGA Kit In Spain 1/21/2015
Cell Therapy Catapult And Trakcel To Collaborate On Research Project 1/20/2015
Kingworld Medicines Forms Marketing/Distribution Alliance With Sinopharm 1/20/2015
Strides Arcolab Limited Snags Huge HIV Pact With Gilead Sciences, Inc. (GILD) 1/20/2015
Evotec AG (EVTG.F) And C4X Discovery Enter Collaboration To Identify Pre-Clinical Development Candidates For Stress-Related Addictive Disorder Programme 1/19/2015
BMG Pharma S.r.l Grants The Exclusive Distribution Rights For Gelx® Oral Gel And Gelx® Spray For The Treatment Of Oral Mucositis In Cancer Patients To Ferrer Internacional 1/19/2015
Solasia Pharma K.K. And Meiji Seika Pharma Announce License And Collaboration Agreement For Darinaparsin (Intravenous Formulation) 1/19/2015
VECT-HORUS Announces The Signing Of A Scientific Collaboration Agreement With Sanofi (SAN.PA) 1/19/2015
UCB SA, Neuropore to Develop Parkinson's Treatment in $480 Million Deal 1/16/2015
Sanofi (SAN.PA), Boehringer Ingelheim Corporation Forge Biologics Pact 1/15/2015
Evotec AG (EVTG.F) Achieves Further Milestones In TargetAD Collaboration With Janssen Pharmaceutical Inc. 1/15/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Another Day, Another $750 Million Antibiotic Deal for Roche (RHHBY) 1/14/2015
Oxford BioTherapeutics Grants An Exclusive License To Boehringer Ingelheim For Development And Commercialization Of Antibody Products To An Oncology Target 1/14/2015
Treeway Announces License And Collaboration Agreement With uniQure To Develop A Gene Therapy For Amyotrophic Lateral Sclerosis (ALS) 1/14/2015
National Research Council of Canada And KalGene Pharmaceuticals Announce License Agreement For The Development Of Novel Alzheimer's Therapeutics 1/14/2015
Boehringer Ingelheim Corporation And Vanderbilt University Join Forces To Develop New Ras Inhibitors For Cancer Treatment 1/14/2015
Tianyin Pharmaceutical Co, Inc. To Form Strategic Alliance With Buchang Pharma 1/14/2015
Merck & Co. (MRK) Jumps Into RNA Frenzy With $100 Million Bet on Moderna Therapeutics, Inc. 1/14/2015
Novartis AG (NVS), Qualcomm Launch $100 Million Fund for Innovative Health Startups 1/14/2015
Shanghai Biotech Forms Genomic CRO Alliance With AKESOgen, Inc. 1/13/2015
Therapix And Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing And Royalty Agreement 1/13/2015
New Partnership In Russia And CIS Further Expands Footprint For EffRx Proprietary Technologies 1/13/2015
Allegro Ophthalmics LLC And Hanmi Pharmaceutical, Co., Ltd Announce Strategic Investment And Collaboration To Develop And Market Luminate® In The Republic Of Korea And China 1/13/2015
Esteve S.A. (Laboratorios Del Dr. Esteve S.A.) Could Bank $1 Billion From Mundipharma AG, Purdue Pharma L.P. Pain Pact 1/12/2015
Boehringer Ingelheim Corporation And Yale University Collaborate To Investigate Novel Immunotherapy Targets Across Several Therapeutic Areas 1/12/2015
Precision NanoSystems And Arcus Therapeutics, LLC Announce A Partnership For The Manufacture Of RNA Medicines 1/9/2015
Novartis AG (NVS) Strikes First-of-its-Kind Biotech Deal for Next Generation Drugs 1/9/2015
Incyte Corporation (INCY), Agenus (AGEN) Strike $410 Million+ Immuno-Oncology Antibodies Pact 1/9/2015
Helsinn And Pharmacosmos A/S Enter Into An Exclusive License Agreement For The Development And Commercialization Of Monofer® In US 1/8/2015
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015
MRC Technology To Manage Diabetes UK’s IP 1/8/2015
Proteros biostructures GmbH Enters Into A Collaboration With Bayer To Develop New Cardiovascular Drug Compounds For An Integral Membrane Protein 1/8/2015
Abcam plc (ABC.L) Signs Exclusive Partnership Agreement With A*STAR’s Institute Of Molecular And Cell Biology 1/8/2015
Mexichem Acquires The Distribution And Sale License For HFC-227ea/P Medical Propellant From Dupont Fluorochemicals 1/8/2015
Shenzhen Hybio Pharma Sells US Rights For Generic MS Drug To Akorn, Inc. (AKN) 1/8/2015
Syndax Pharmaceuticals Inc. Snags $125 Million Deal With Kyowa Hakko Kirin 1/8/2015
Evotec AG (EVTG.F) And Padlock Therapeutics Announce Initial Success And Extension Of Long-Term Collaboration 1/7/2015
GenSight Biologics, Pixium Vision And Fondation Voir Et Entendre Join Forces And Benefit From A Total € 18.5 Million Funding For SIGHT AGAIN As Part Of The Investment For The Future 1/7/2015
Addex Therapeutics (ADXN.SW) And NIAAA Enter Collaboration To Evaluate ADX71441 In Alcohol Use Disorder 1/7/2015
Swedish Orphan Biovitrum Extends And Restructures Distribution Agreement With Exelixis, Inc. (EXEL) For Cometriq 1/7/2015
AstraZeneca PLC (AZN), GlaxoSmithKline (GSK) Turn to Crowd-Funding Experiment to Reinvigorate Slumping Pipeline 1/6/2015
Vectura Group plc (VEC.L) Signs Global Development And Licence Agreement With Janssen Biotech Inc. (JNJ) In Asthma/COPD 1/6/2015
TxCell, Ferring B.V. Strike €75 Million Plus Deal 1/2/2015
Tikcro Technologies Signs Research And License Agreement Regarding Cancer Immune Checkpoint Antibodies 12/30/2014
Ariad Pharmaceuticals, Inc. (ARIA) Announces Commercialization Agreement For Iclusig In Seven Central And Eastern European Countries 12/30/2014
OncoGenex Pharmaceuticals Inc. (OGXI) Snags $27 Million and Prostate/Lung Cancer Rights From Teva Pharmaceutical Industries Limited (TEVA) 12/30/2014
Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ) Expand Existing HIV R&D Pact 12/29/2014
PPD, Inc. (PPDI) And Shin Nippon Biomedical Laboratories Announce Japanese Clinical Development Joint Venture And Additional Collaborations 12/29/2014
AMAG Pharmaceuticals, Inc. (AMAG), Takeda (TKPYY) Abandon $280 Million Ferumoxytol Pact 12/29/2014
BioLineRx Ltd. Out-Licenses Novel Skin Lesion Treatment To Omega Pharma 12/24/2014
Therapix Enters Strategic Collaboration For Development And Commercialization Of Oral Anti-CD3 Antibody In China 12/23/2014
Phylogica Ltd. Grabs $142 Million Deal With Genentech (RHHBY) 12/22/2014
Eddingpharm To Market Afib Drug In China For Cardiome Pharma Corp. (COM.TO) 12/22/2014
Weijian Pharma To Market Infertility Drug In China For LG Life Sciences, Ltd. 12/22/2014



//-->